Recent Updates
Recently added Catalysts
BiopharmaWatch Research3 min read

FDA Drug Approval Process

What is the FDA Approval Process?
The FDA drug approval process ensures new medicines are safe and effective before reaching the market. It involves four key stages:

  1. Pre-clinical and IND (Investigational New Drug) Application
    Includes lab and animal testing to assess safety and toxicity, followed by submitting an IND to the FDA for approval to start human trials.

  2. Clinical Trials
    Human testing occurs in multiple phases (Phases 1–3) to evaluate safety, effectiveness, and optimal dosing.

  3. New Drug Application (NDA) Review
    The manufacturer submits all data for FDA review, including results from clinical trials, side effects, and manufacturing details.

  4. Post-Marketing Risk Assessments (Phase 4)
    Ongoing safety monitoring after the drug is on the market, identifying long-term effects and rare side effects.

The FDA Center for Drug Evaluation and Research (CDER) oversees this process, relying on expert reviews by scientists and clinicians.

How Long Does Drug Approval Take?
The entire process, from discovery to market, can take 12–15 years. Early stages include pre-clinical research, where potential drugs are screened for toxicity and effectiveness in animals. Once approved for human trials, the process progresses through:

  • Phase 1: Tests safety in 20–80 healthy volunteers over ~1 year.

  • Phase 2: Evaluates effectiveness in 40–300 patients over ~2 years.

  • Phase 3: Assesses effectiveness and side effects in hundreds to thousands of patients over ~3 years.

Only 1 in 1,000 compounds tested in labs makes it to human trials.

Special FDA Designations to Expedite Approval
The FDA offers pathways to accelerate drug development for serious or rare conditions:

  • Orphan Drug Designation: For rare diseases affecting fewer than 200,000 people, with benefits like 7 years of exclusivity.

  • Accelerated Approval: Allows early approval based on surrogate markers, requiring post-marketing studies to confirm benefits.

  • Fast Track: Speeds up review for drugs addressing unmet medical needs.

  • Breakthrough Therapy: For drugs showing significant improvement over current treatments in preliminary trials.

  • Priority Review: Shortens the review period from 10 months to 6 for drugs offering significant advancements in care.

What is a New Drug Application (NDA)?
An NDA is the formal request for FDA approval to market a drug. It includes extensive data on safety, efficacy, manufacturing, and labeling. The FDA aims to review:

  • Standard drugs within 10 months.

  • Priority drugs within 6 months.

Who Reviews FDA Applications?
An FDA Advisory Board, comprising independent experts like doctors, pharmacists, and statisticians, reviews applications. The board recommends approval or rejection, though the FDA is not obligated to follow its advice.

Costs and Post-Approval Considerations
Developing a new drug can cost $1–2.7 billion, depending on its type. After approval:

  • The drug becomes available for prescription.

  • Post-marketing surveillance continues to ensure safety and effectiveness.

The FDA does not regulate drug prices, unlike many other countries.

Frequently asked questions

What are the main stages of the FDA drug approval process?
The FDA drug approval process consists of four key stages: Pre-clinical and IND application, clinical trials (Phases 1-3), New Drug Application (NDA) review, and post-marketing risk assessments. Initially, lab and animal testing assess safety, followed by human trials to evaluate effectiveness. After submitting an NDA, the FDA reviews all data before granting approval.
How long does the FDA drug approval process take?
The entire FDA drug approval process can take 12 to 15 years from discovery to market. This timeline includes pre-clinical research, followed by three phases of clinical trials, each lasting several years. Factors like the complexity of the drug and the necessity for additional studies can influence the duration.
What is a New Drug Application (NDA) in the FDA drug approval process?
A New Drug Application (NDA) is a formal request submitted to the FDA for approval to market a new drug. It includes comprehensive data on the drug's safety, efficacy, manufacturing processes, and labeling. The FDA typically reviews standard NDAs within 10 months and priority NDAs within 6 months.
What special designations does the FDA offer to expedite drug approval?
The FDA provides several designations to expedite the drug approval process for serious or rare conditions. These include Orphan Drug Designation for rare diseases, Accelerated Approval based on surrogate markers, Fast Track for unmet medical needs, Breakthrough Therapy for significant improvements, and Priority Review to shorten the review timeline.
What role does post-marketing surveillance play in the FDA drug approval process?
Post-marketing surveillance is a critical phase of the FDA drug approval process that occurs after a drug is on the market. It involves ongoing monitoring to identify long-term effects and rare side effects that may not have been apparent during clinical trials. This ensures continued safety and effectiveness of the drug for patients.